Stock
Investing.com — Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an “overweight” rating, shifting from “equal-weight,” and have also increased their price...
Hi, what are you looking for?
Investing.com — Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an “overweight” rating, shifting from “equal-weight,” and have also increased their price...
Investing.com – The possibility of interest rate remaining higher than anticipated for a longer period of time could be “ideal” for Axos Financial (NYSE:AX),...
By Supantha Mukherjee and Philip Blenkinsop STOCKHOLM (Reuters) – Elon Musk’s expected hosting of Alice Weidel, leader of the far-right Alternative for Germany (AfD)...
By Alun John, Harry Robertson and Naomi Rovnick LONDON (Reuters) – British markets are among the biggest victims of a global bond selloff that...
Supporters and friends of the late President Carter will attend his funeral Thursday at Washington, D.C.’s National Cathedral. The service, scheduled to begin at...
Investing.com – India stocks were lower after the close on Thursday, as losses in the Real Estate, Oil & Gas and Power sectors led...
Shell (LON:SHEL) and Repsol (OTC:REPYY) have been upgraded to “buy” by analysts at UBS Global Research analysts, while Eni has been downgraded to a...
Investing.com – A recent jump in semiconductor stocks is tipped to hit a plateau later this year, according to analysts at Jefferies. Chipmakers soared...
Investing.com — Barclays (LON:BARC) has upgraded Partners Group to “overweight,” reflecting increased confidence in its outlook for 2025, in a note dated Thursday. This...
By James Davey, Paul Sandle and Sarah Young LONDON (Reuters) – Shares in Britain’s Marks & Spencer (OTC:MAKSY) and other retailers fell on Thursday,...